NRAS mutation status is an independent prognostic factor in metastatic melanoma

Research output: Contribution to journalArticle

377 Scopus citations

    Fingerprint

Cite this

Jakob, J. A., Bassett, R. L., Ng, C. S., Curry, J. L., Joseph, R. W., Alvarado, G. C., Rohlfs, M. L., Richard, J., Gershenwald, J. E., Kim, K. B., Lazar, A. J., Hwu, P., & Davies, M. A. (2012). NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer, 118(16), 4014-4023. https://doi.org/10.1002/cncr.26724